Randomized, Double Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

被引：0
|
作者：
Rosas, I. [1 ]
Solomon, J. [2 ]
Donoff, S. [3 ]
Woodhead, F. [4 ]
Raghu, G. [5 ]
Hilary, G. [6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Colorado, Denver, CO 80202 USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Univ Leicester, Leicester, Leics, England
[5] Univ Washington, Seattle, WA 98195 USA
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] TRAIL NETWORK, Seattle, WA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4534
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4534
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
    Hobbs, Kathryn
    Deodhar, Atul
    Wang, Brian
    Bitman, Bojena
    Nussbaum, Joyce
    Chung, James
    Collier, David H.
    SPRINGERPLUS, 2015, 4 : 1 - 7
  • [42] A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis
    Snowden, JA
    Biggs, JC
    Milliken, ST
    Fuller, A
    Staniforth, D
    Passuello, F
    Renwick, J
    Brooks, PM
    BONE MARROW TRANSPLANTATION, 1998, 22 (11) : 1035 - 1041
  • [43] A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis
    JA Snowden
    JC Biggs
    ST Milliken
    A Fuller
    D Staniforth
    F Passuello
    J Renwick
    PM Brooks
    Bone Marrow Transplantation, 1998, 22 : 1035 - 1041
  • [44] RETRACTED: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS (Retracted Article)
    Leber, Andrew
    Hontecillas, Raquel
    Tubau-Juni, Nuria
    Lichtiger, Simon
    Bassaganya-Riera, Josep
    GASTROENTEROLOGY, 2022, 162 (03) : S112 - S112
  • [45] Efficacy and safety of guselkumab in biologic-naive patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial
    Gladman, Dafna D.
    Mease, Philip J.
    Bird, Paul
    Soriano, Enrique R.
    Chakravarty, Soumya D.
    Shawi, May
    Xu, Stephen
    Quinn, Sean T.
    Gong, Cinty
    Leibowitz, Evan
    Poddubnyy, Denis
    Tam, Lai-Shan
    Helliwell, Philip S.
    Kavanaugh, Arthur
    Deodhar, Atul
    Ostergaard, Mikkel
    Baraliakos, Xenofon
    TRIALS, 2022, 23 (01)
  • [46] Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis - A double-blind, randomized, placebo-controlled trial
    van Dongen, Henrike
    van Aken, Jill
    Lard, Leroy R.
    Visser, Karen
    Ronday, H. Karel
    Hulsmans, Harry M. J.
    Speyer, Irene
    Westedt, Marie-Louise
    Peeters, Andre J.
    Allaart, Cornelia F.
    Toes, Rene E. M.
    Breedveld, Ferdinand C.
    Huizinga, Tom W. J.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1424 - 1432
  • [47] A double-blind, placebo-controlled study of the efficacy and safety of four different doses of etanercept in patients with rheumatoid arthritis.
    Ericson, ML
    Wajdula, J
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S82 - S82
  • [48] One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
    Genovese, Mark C.
    Durez, Patrick
    Richards, Hanno B.
    Supronik, Jerzy
    Dokoupilova, Eva
    Aelion, Jacob A.
    Lee, Sang-Heon
    Codding, Christine E.
    Kellner, Herbert
    Ikawa, Takashi
    Hugot, Sophie
    Ligozio, Gregory
    Mpofu, Shephard
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (03) : 414 - 421
  • [49] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
    Papp, K
    Mease, P
    Garovoy, M
    Zhang, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
  • [50] EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS: PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
    Mazurov, V.
    Korolev, M.
    Kundzer, A.
    Soroka, N.
    Kastanayan, A.
    Povarova, T.
    Plaksina, T.
    Antipova, O.
    Kretchikova, D.
    Smakotina, S.
    Tciupa, O.
    Raskina, T.
    Kropotina, T.
    Nesmeyanova, O.
    Popova, T.
    Dokukina, E.
    Plotnikova, A.
    Lutskii, A.
    Zinkina-Orihan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 550 - 551
12345